Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

CC Chemokine Receptor Type 5 Market Size, Value And Growth Trends Through 2030

The market for cc chemokine receptor type 5 has experienced significant expansion over the past few years, with projections indicating continued robust growth. It is anticipated to increase from $1.54 billion in 2025 to $1.7 billion in 2026, demonstrating a compound annual growth rate of 10.1%. This surge in market value during the historical period is attributable to a confluence of factors, including the identification of CCR5’s involvement in HIV infection, the initial stages of developing CCR5 inhibitors, a broader expansion of immunological research initiatives, the progression of clinical trials focused on inflammatory conditions, and the increasing prevalence of therapies specifically targeting receptors.

The market for the cc chemokine receptor type 5 is projected to experience substantial expansion over the upcoming years, reaching an estimated $2.48 billion by 2030 with a compound annual growth rate of 9.9%. This anticipated growth throughout the forecast period is underpinned by several key drivers, including the proliferation of personalized immunotherapies, continuous innovation in HIV treatment strategies, a robust pipeline for oncology drug development, increased investment in research focused on immune modulation, and significant advancements in the design of drugs targeting specific receptors. During this same period, several significant trends are expected to shape the market, such as the growing development of CCR5 antagonist therapies, a heightened focus on research within the fields of HIV and immunology, the broadening of CCR5 applications within oncology, a greater embrace of targeted immune modulation approaches, and an intensified dedication to the development of precision medicines.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18290&type=smp

CC Chemokine Receptor Type 5 Market Growth Factors Supporting Long-Term Expansion

The growing incidence of chronic illnesses is anticipated to spur the expansion of the market for the CC chemokine receptor type 5. Chronic diseases, defined as long-lasting health conditions like cardiovascular ailments, diabetes, and joint inflammation, characteristically develop gradually and necessitate continuous medical attention. Factors such as an aging global population and a rise in lifestyle-related risk factors, including suboptimal diets, sedentary habits, and obesity, are contributing to the increasing burden of these conditions. The CC Chemokine Receptor Type 5 (CCR5) plays a vital role in the pathogenesis of certain chronic diseases, notably Human Immunodeficiency Virus (HIV), by functioning as a crucial co-receptor that facilitates the virus’s entry into and infection of immune cells, thereby significantly impacting disease progression. Illustrating this trend, data from the Centers for Disease Control and Prevention (CDC) indicated that in 2023, approximately 194 million adults in the U.S., representing 76.4% of this demographic, reported having at least one chronic condition, with prevalence rates of 59.5% among younger adults, 78.4% among middle-aged adults, and a striking 93.0% among older adults. Consequently, the escalating prevalence of chronic diseases serves as a primary catalyst for the growth observed in the CC chemokine receptor type 5 market.

The escalating global prevalence of HIV is poised to be a significant driver for the CC chemokine receptor type 5 market’s advancement. Human Immunodeficiency Virus (HIV) targets and compromises the immune system, diminishing the body’s capacity to fend off infections and diseases. Unsafe sexual behaviors are a primary factor contributing to the increased transmission of HIV between individuals. The CC Chemokine Receptor Type 5 (CCR5) is instrumental in the HIV life cycle, serving as a co-receptor that, in conjunction with CD4 receptors, assists the virus in penetrating and infecting immune cells, thus enabling its replication. For perspective, the Minority HIV/AIDS Fund (MHAF) reported in October 2025 that an estimated 39.9 million people globally were living with HIV in 2023, comprising 38.6 million adults and 1.4 million children, a figure that reflects an increase over prior years. This upward trend in HIV prevalence directly fuels the expansion of the CC chemokine receptor type 5 market.

CC Chemokine Receptor Type 5 Market Segment Landscape: Which Areas Lead Market Development?

The cc chemokine receptor type 5 market covered in this report is segmented –

1) By Type: BMS-813160, AG-1105, DS-001, Other Types

2) By Distribution Channel: Hospitals, Clinics

3) By Application: Infectious Disease, Immunology, Oncology, Other Applications

4) By End User: Research Institutes, Pharmaceutical Companies, Healthcare Facilities

Subsegments:

1) By BMS-813160: CCR5 Antagonist For HIV Treatment, CCR5 Antagonist For Inflammatory Diseases

2) By AG-1105: CCR5 Antagonist For Autoimmune Disorders, CCR5 Antagonist For Cancer Therapy

3) By DS-001: CCR5 Inhibitor For Cancer Treatment, DS-001 For Inflammatory Disease Management

4) By Other Types: Novel CCR5 Antagonists, Dual-Target CCR5 Antagonists

CC Chemokine Receptor Type 5 Market Industry Trends Shaping Future Revenue Growth

Key players within the CC chemokine receptor type 5 market are prioritizing the creation of novel therapeutics, specifically CCR5 antagonists, as a strategy for market differentiation. These antagonists function by obstructing the CC chemokine receptor type 5 (CCR5) on cells of the immune system, thereby impeding the attachment and entry of certain infectious agents, including HIV, and consequently blocking infection while also influencing immune system functions. An illustrative development occurred in February 2024 when CytoDyn Inc., a biotechnology firm headquartered in the United States, revealed that the U.S. Food and Drug Administration (FDA) had removed its clinical hold on leronlimab, granting permission to proceed with a planned HIV clinical trial examining leronlimab’s effects on persistent inflammation. Leronlimab, recognized as a CCR5 antagonist (and formerly designated PRO 140), exhibits considerable therapeutic potential across a spectrum of conditions, with ongoing research exploring its efficacy in treating ailments such as HIV and various cancers.

CC Chemokine Receptor Type 5 Market Industry Leaders And Market Competition

Major companies operating in the cc chemokine receptor type 5 market are Cytodyn Inc., Gilead Sciences Inc., ViiV Healthcare Limited, Pfizer Inc., Bristol Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, AbbVie Inc., AstraZeneca plc, Novartis AG, Sanofi SA, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim International GmbH, F Hoffmann-La Roche Ltd, Ono Pharmaceutical Co Ltd, Avexa Limited, Incyte Corporation, Humanigen Inc., Biogen Inc.

Access The Complete CC Chemokine Receptor Type 5 Market Report:

https://www.thebusinessresearchcompany.com/report/cc-chemokine-receptor-type-5-global-market-report

CC Chemokine Receptor Type 5 Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the CC chemokine receptor type 5 market in 2025. The regions covered in the cc chemokine receptor type 5 market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model